American Portfolios Advisors’s Adial Pharmaceuticals ADIL Stock Holding History

American Portfolios Advisors’s Portfolio ADIL Stock Details ADIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.93K	Buy	+9	New	+$4.06K	﹤0.01%	3134

Other funds holding ADIL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

American Portfolios Advisors's ADIL Position: Q3 2022 in Review

American Portfolios Advisors opened a new position in Adial Pharmaceuticals (ADIL) in Q3 2022: 9 shares worth $1.93K. The stake represents ﹤0.01% of the portfolio and ranks #3134 among its holdings.

25 funds tracked by Wall St. Rank hold ADIL as of Q3 2022.

American Portfolios Advisors held 9 shares of Adial Pharmaceuticals worth $1.93K as of Q3 2022.
Adial Pharmaceuticals was a new American Portfolios Advisors position in Q3 2022.
Adial Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3134 holding.
25 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.